CITECH Sponsors Research At Hebrew University of Jerusalem On cannabis Therapy For Obesity Induced Fatty Liver Disease
CITECH Sponsors Research At Hebrew University of Jerusalem On cannabis Therapy For Obesity Induced Fatty Liver Disease
CIITECH, a UK-Israel cannabis biotech startup has announced that it has selected to sponsor a research project with the Multidisciplinary Center on Cannabinoid Research of the Hebrew University of Jerusalem, focused on the therapeutic benefit of phytocannabinoids to assist in the treatment of Non Alcoholic Fatty Liver Disease (NAFLD), a common and potentially serious condition often associated with obesity, and a major cause of morbidity and mortality.
Go to Source
Powered by WPeMatico